Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V S Varma

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|October 12, 2004
RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulationRamesh Panchagnula, Puneet Sharma, Sateesh Khandavilli, et al.
Drug Development and Industrial Pharmacy|August 4, 2006
High-throughput evaluation of non-swellable controlled release matrix tabletsR Panchagnula, A Gupta, S Kandavilli, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 25, 2025
Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug-Drug InteractionsAarzoo Thakur, Sumathy Mathialagan, Emi Kimoto, et al.
Clinical Pharmacology and Therapeutics|November 13, 2020
Drug-Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker-Informed ApproachSumathy Mathialagan, Bo Feng, A David Rodrigues, et al.
Clinical Pharmacology and Therapeutics|March 31, 2019
Clopidogrel as a Perpetrator of Drug-Drug Interactions: A Challenge for Quantitative Predictions?Manthena V S Varma, Yi-An Bi, Sarah Lazzaro, et al.
Journal of Medicinal Chemistry|January 6, 2025
Positioning Enzyme- and Transporter-Based Precipitant Drug-Drug Interaction Studies in Drug DesignThomas Schroeter, Kimberly Lapham, Manthena V S Varma, et al.
Molecular Pharmaceutics|June 16, 2018
Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary HepatocytesAnna Vildhede, Emi Kimoto, A David Rodrigues, et al.
Die Pharmazie|January 10, 2006
Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug effluxR Panchagnula, T Bansal, M V S Varma, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 3, 2004
Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studiesRamesh Panchagnula, Tripta Bansal, Manthena V S Varma, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 4, 2010
Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease stateBo Feng, Jennnifer L LaPerle, George Chang, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Farmaco (Societa Chimica Italiana : 1989)|October 12, 2004
RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulationRamesh Panchagnula, Puneet Sharma, Sateesh Khandavilli, et al.
Drug Development and Industrial Pharmacy|August 4, 2006
High-throughput evaluation of non-swellable controlled release matrix tabletsR Panchagnula, A Gupta, S Kandavilli, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 25, 2025
Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug-Drug InteractionsAarzoo Thakur, Sumathy Mathialagan, Emi Kimoto, et al.
Clinical Pharmacology and Therapeutics|November 13, 2020
Drug-Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker-Informed ApproachSumathy Mathialagan, Bo Feng, A David Rodrigues, et al.
Clinical Pharmacology and Therapeutics|March 31, 2019
Clopidogrel as a Perpetrator of Drug-Drug Interactions: A Challenge for Quantitative Predictions?Manthena V S Varma, Yi-An Bi, Sarah Lazzaro, et al.
Journal of Medicinal Chemistry|January 6, 2025
Positioning Enzyme- and Transporter-Based Precipitant Drug-Drug Interaction Studies in Drug DesignThomas Schroeter, Kimberly Lapham, Manthena V S Varma, et al.
Molecular Pharmaceutics|June 16, 2018
Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary HepatocytesAnna Vildhede, Emi Kimoto, A David Rodrigues, et al.
Die Pharmazie|January 10, 2006
Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug effluxR Panchagnula, T Bansal, M V S Varma, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 3, 2004
Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studiesRamesh Panchagnula, Tripta Bansal, Manthena V S Varma, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 4, 2010
Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease stateBo Feng, Jennnifer L LaPerle, George Chang, et al.
Pageof 10